Aims and Strategy

e-Therapeutics’ aims are to discover and out-license effective new medicines. We have a strong balance sheet which enables us to plan for the optimal point at which to out-license our drug assets to maximise returns for our shareholders whilst we recognise that there are, at present, opportunities for much earlier stage out-licensing of candidates for certain indications.